From 1st April 2024, the UK government is introducing a unified R&D tax relief scheme, replacing the SME and RDEC schemes. This article outlines the key changes, including updated rules on subcontracting, overseas R&D, and support for R&D-intensive SMEs. Learn how the new scheme affects your business and what steps you need to take to stay compliant and maximise your claim.

In today’s competitive business landscape, standing still is not an option. Growth-hungry companies must continually innovate, not just to stay relevant, but to lead. But innovation on its own isn’t enough. Scaling a business takes more than a great idea; it takes strategy, resilience, and the right support network to turn innovation into sustainable success.

Inventya Ltd is proud to announce that we have been featured in the Financial Times’ ninth annual FT1000: Europe’s Fastest Growing Companies 2025 list. This prestigious ranking, compiled in collaboration with Statista, recognizes the top 1,000 European companies that have demonstrated exceptional revenue growth and resilience over the past years.

Inventya requires access to an online database or market intelligence platform for discovering, tracking and understanding high growth UK businesses. This contract is for 96 licenses and will include training and support services.

Scaling isn’t just about rapid growth, it’s about sustainable growth. While high growth often signals momentum, scaling requires systems, processes, and resources that can keep pace with expansion. Before making the leap, assess key metrics like consistent revenue growth, customer retention, and strong unit economics. Beyond numbers, evaluate whether your team and operational processes are efficient and scalable.

The AIRCARE Project, a European initiative funded under the Horizon Europe Programme, has secured almost eight million euros to transform the diagnosis and treatment of Upper Aerodigestive Tract (UADT) cancers. Coordinated by the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology), AIRCARE brings together leading research institutions, hospitals, and industry experts across Europe. The project aims to introduce advanced AI-driven and robotic technologies into clinical workflows, offering new standards of care in the detection, diagnosis, and treatment of UADT cancers.